WideTrial to Support Cost Recovery for Personalized Cancer Vaccine Trial and Expanded Access Program
Astro Bug/10207630
Trending...
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Experience the Future: Tokenum Launches the First Gasless Swap on Ethereum, BSC, and Polygon
Basket trial of neoantigen synthetic long peptide vaccines for patients with advanced malignancy, run by the Jaime Leandro Foundation in association with Washington University of St. Louis
SAN FRANCISCO - AstroBug -- WideTrial, Inc. will provide key regulatory support to a personalized cancer treatment program run by the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) in association with Washington University School of Medicine in St. Louis.
In a basket trial for neoantigen synthetic long peptide vaccines, patients with advanced malignancies will be given a customized mix of neoantigen peptides based on their individual tumor mutation profiles. Cancer patients who do not meet the trial's eligibility criteria or who are geographically remote from the trial centers may still gain the personalized treatment through an Expanded Access Program (an "EAP").
WideTrial will conduct the planning and regulatory filings required for FDA-authorized Cost Recovery for both the research trial and the EAP.
"The recent draft Guidance on Charging for Investigational Treatment under an IND was a great step by FDA to clarify Cost Recovery rules, but it's still a complicated matter," said Jess Rabourn, CEO of WideTrial. "Our company was created to make this space easier to navigate, ensuring that non-traditional clinical trials, including Expanded Access Programs, are feasible for more clinics to offer to more patients as a care option."
More on Astro Bug
In the United States, all Expanded Access Programs and some research trials are eligible for Cost Recovery. This permits a sponsor to pass through some of its costs to interested parties. It is intended for cases in which the cost burden on the sponsor would otherwise severely restrict the feasibility or scope of the program.
"We reached out to WideTrial because of Jess's long-standing leadership in Expanded Access but also for his reputation for helping companies understand and utilize Cost Recovery in their clinical development," said William Hoos, President of JLF. "It's been a successful partnership so far."
WideTrial Inc. is a Silicon Valley based health-tech corporation. Its mission is to make investigational treatment options accessible to all patients with serious and life-threatening health conditions. To learn more, visit widetrial.com
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) is a 501(c)3 nonprofit organization that organizes the complex process necessary to give patients and doctors access to personalized neoantigen vaccines.
In a basket trial for neoantigen synthetic long peptide vaccines, patients with advanced malignancies will be given a customized mix of neoantigen peptides based on their individual tumor mutation profiles. Cancer patients who do not meet the trial's eligibility criteria or who are geographically remote from the trial centers may still gain the personalized treatment through an Expanded Access Program (an "EAP").
WideTrial will conduct the planning and regulatory filings required for FDA-authorized Cost Recovery for both the research trial and the EAP.
"The recent draft Guidance on Charging for Investigational Treatment under an IND was a great step by FDA to clarify Cost Recovery rules, but it's still a complicated matter," said Jess Rabourn, CEO of WideTrial. "Our company was created to make this space easier to navigate, ensuring that non-traditional clinical trials, including Expanded Access Programs, are feasible for more clinics to offer to more patients as a care option."
More on Astro Bug
- Long Island businessman turned recording artist, John Beyer, to release his first love song aptly titled, …"Love You More"
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Exploring the World of Web3? Lympid Puts Users Front and Center
- "Regenerating Life": documentary film challenges current assumptions about climate change
- Flint's Got Talent Returns To Showcase Creativity In Community
In the United States, all Expanded Access Programs and some research trials are eligible for Cost Recovery. This permits a sponsor to pass through some of its costs to interested parties. It is intended for cases in which the cost burden on the sponsor would otherwise severely restrict the feasibility or scope of the program.
"We reached out to WideTrial because of Jess's long-standing leadership in Expanded Access but also for his reputation for helping companies understand and utilize Cost Recovery in their clinical development," said William Hoos, President of JLF. "It's been a successful partnership so far."
WideTrial Inc. is a Silicon Valley based health-tech corporation. Its mission is to make investigational treatment options accessible to all patients with serious and life-threatening health conditions. To learn more, visit widetrial.com
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) is a 501(c)3 nonprofit organization that organizes the complex process necessary to give patients and doctors access to personalized neoantigen vaccines.
Source: WideTrial
0 Comments
Latest on Astro Bug
- Tobu Railway Launches Its Latest Model "Spacia X" Express Train with 40% Reduced CO2 Emissions Compared with the Previous Spacia Fleet
- Axiros Launches a New Release of their USP Agent - AXACT 2023.4
- North Carolina Entrepreneur Awarded 2023 Small Business Advocate of the Year By NSBA
- Instant Gourmet Coffee With The Authentic Taste & Refreshing Smell Of Cafe De Olla, Infused With The Wonderful Health Benefits Of Superfoods
- Berlin Packaging Fires Female Executive Following Complaints of Discrimination
- Falcomm selected for 2023 TechCrunch Startup Battlefield 200
- Patton Acquires Tone Commander
- Customer Agility Framework™ soft launch
- New Kickstarter Campaign - 7 Exclusive Novels from Ray Keating
- Moolwan releases 10 new Home Decor Items to help customers decorate their homes into opulent masterpieces
- City of Fairfax triples access to public restrooms with innovative high tech solution
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
- 5 Steps to an Exceptional Presentation
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Axiros ACS solution enables Earth Broadband to manage multiple client devices and CPE on AX69
- Art Exhibition - David Mackenzie: Outside the Lines
- Private Offices, Virtual Offices & Meeting Room in Calgary Alberta
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
- Desert Outdoor Lighting Announces a 10% Discount for the Beginning of the Holiday Lighting Season
- Mountain Fresh Water Systems Announces 5% End-of-Summer Discount on All Services